TrustCore Financial Services’s Usana Health Sciences USNA Stock Holding History

TrustCore Financial Services’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-80	Closed	-$5K	–	954
2020 Q1	$5K	Hold	80	–	–	﹤0.01%	696
2019 Q4	$6K	Hold	80	–	–	﹤0.01%	720
2019 Q3	$5K	Hold	80	–	–	﹤0.01%	758
2019 Q2	$6K	Hold	80	–	–	﹤0.01%	714
2019 Q1	$7K	Buy	+80	New	+$8.35K	﹤0.01%	628

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TrustCore Financial Services's USNA Position: Q2 2020 in Review

TrustCore Financial Services sold out of Usana Health Sciences (USNA) in Q2 2020, closing a stake of 80 shares — an estimated $5K sold.

TrustCore Financial Services first reported a position in USNA in Q1 2019 and held it in 5 quarters. The position peaked at $7K in Q1 2019. 192 funds tracked by Wall St. Rank hold USNA as of Q2 2020.

TrustCore Financial Services reported no remaining Usana Health Sciences position as of Q2 2020 after selling out during the quarter.
TrustCore Financial Services sold 80 Usana Health Sciences shares in Q2 2020, an estimated $5K.
TrustCore Financial Services first reported a position in Usana Health Sciences in Q1 2019 and held it in 5 quarters.
TrustCore Financial Services's Usana Health Sciences position peaked at $7K in Q1 2019.
192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2020.

Based on TrustCore Financial Services's 13F filing for Q2 2020, filed 29 Jul 2020.